Skip to content

Connecting business. Building understanding. Advancing peace.

Abu Dhabi Expands Longevity Healthcare Sector Despite Unproven Life Extension Claims

The medical director of Abu Dhabi's flagship longevity facility stated that clinical evidence proving longevity medicine extends human lifespans does not yet exist. The remarks were made as Abu Dhabi accelerates efforts to regulate and commercialise the sector through dedicated clinical standards and health-tech partnerships. The emirate has enforced a Healthy Longevity Medicine Clinic Standard while integrating health-tracking metrics into government platforms.

Issuing authority
Department of Health Abu Dhabi
Jurisdiction
Abu Dhabi, United Arab Emirates
Effective date
April 1, 2025
Stage
Final rule
Official document
Healthy Longevity Medicine Clinic Standard
Official source
news.google.com
Illustration: An empty modern medical consultation room in Abu Dhabi with high-tech diagnostic screens displaying health analytics, clean minimalist c
Illustration

Dr. Rory Melville, medical director of the Institute for Healthier Living Abu Dhabi (IHLAD), told Health Policy Watch at the Abu Dhabi Future Health Summit that there is currently no clinical evidence demonstrating that longevity medicine extends human life. Melville stated that generating definitive proof would require observing patients until the end of their lives, a process spanning several decades.

In November 2024, the Department of Health Abu Dhabi licensed IHLAD as what it described as the world's first specialised Healthy Longevity Medicine Centre. Abu Dhabi has backed this commercial sector by courting AI drug developers, longevity clinicians, and wearable technology manufacturers to expand health monitoring and preventative care.

To govern the emerging field, Abu Dhabi introduced the Healthy Longevity Medicine Clinic Standard, which took effect in April 2025. The regulations classify epigenetic and protein-based biological age tests as optional tools requiring further validation, while mandating that repurposed longevity medications possess positive human randomised controlled trial data. The standards were developed by the Department of Health alongside IHLAD and the Healthy Longevity Medicine Society.

Abu Dhabi has also embedded longevity metrics into its public health infrastructure. The Department of Health operates a health age feature on its Sahatna application via the TAMM government platform, linking consumer wearable data with patient medical records in the Malaffi health information exchange.

Sources

The UECN Brief

Policy updates, China–UAE business news and industry insights, delivered to your inbox.

Language
Subscriptions

Double opt-in: we send a confirmation link. Unsubscribe at any time. Privacy